CA3100633A1 - Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes - Google Patents
Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes Download PDFInfo
- Publication number
- CA3100633A1 CA3100633A1 CA3100633A CA3100633A CA3100633A1 CA 3100633 A1 CA3100633 A1 CA 3100633A1 CA 3100633 A CA3100633 A CA 3100633A CA 3100633 A CA3100633 A CA 3100633A CA 3100633 A1 CA3100633 A1 CA 3100633A1
- Authority
- CA
- Canada
- Prior art keywords
- neutron capture
- composition
- bpmo
- capture agent
- isotope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
- A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3100633A CA3100633A1 (fr) | 2020-11-25 | 2020-11-25 | Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3100633A CA3100633A1 (fr) | 2020-11-25 | 2020-11-25 | Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3100633A1 true CA3100633A1 (fr) | 2022-05-25 |
Family
ID=81751035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3100633A Pending CA3100633A1 (fr) | 2020-11-25 | 2020-11-25 | Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA3100633A1 (fr) |
-
2020
- 2020-11-25 CA CA3100633A patent/CA3100633A1/fr active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ning et al. | Type-I AIE photosensitizer loaded biomimetic system boosting cuproptosis to inhibit breast cancer metastasis and rechallenge | |
| Pan et al. | Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection | |
| Bian et al. | Review of functionalized nanomaterials for photothermal therapy of cancers | |
| Zhong et al. | Copper‐based nanomaterials for cancer theranostics | |
| Li et al. | Red blood cell membrane-enveloped O2 self-supplementing biomimetic nanoparticles for tumor imaging-guided enhanced sonodynamic therapy | |
| Sadiq et al. | A critical review on metal-organic frameworks (MOFs) based nanomaterials for biomedical applications: Designing, recent trends, challenges, and prospects | |
| Jin et al. | Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges | |
| Fan et al. | Biodistribution, degradability and clearance of 2D materials for their biomedical applications | |
| Zhang et al. | X-ray-triggered NO-released Bi–SNO nanoparticles: all-in-one nano-radiosensitizer with photothermal/gas therapy for enhanced radiotherapy | |
| Yang et al. | Rod-shape MSN@ MoS2 nanoplatform for FL/MSOT/CT imaging-guided photothermal and photodynamic therapy | |
| JP6042450B2 (ja) | 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用 | |
| Allard et al. | 188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas | |
| Liu et al. | Ultrafast synthesizing bismuth mesoporous nanolitchi radiosensitizer loading high dose DOX for CT-guided enhanced chemoradiotherapy | |
| Jiang et al. | Radiodynamic therapy with CsI (na)@ MgO nanoparticles and 5-aminolevulinic acid | |
| US20220080046A1 (en) | Methods of Performing Neutron Capture Therapy | |
| Yue et al. | Advances of nanotechnology applied to cancer stem cells | |
| Li et al. | Tantalum-carbon-integrated nanozymes as a nano-radiosensitizer for radiotherapy enhancement | |
| CN106512027A (zh) | 四氧化三铁/壳聚糖/吲哚菁绿复合粒子及其制备与应用 | |
| Wang et al. | α-Fe2O3@ Au-PEG-Ce6-Gd nanoparticles as acidic H2O2-driven oxygenators for multimodal imaging and synergistic tumor therapy | |
| CA3100633A1 (fr) | Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes | |
| JP7489926B2 (ja) | 中性子捕捉療法のための生分解性ナノキャリア(bpmo)およびその方法 | |
| RU2780888C2 (ru) | БИОРАЗЛАГАЕМЫЙ(-МЫЕ) НАНОНОСИТЕЛЬ(-ЛИ) (BPMOs) ДЛЯ НЕЙТРОН-ЗАХВАТНОЙ ТЕРАПИИ И ЕЕ МЕТОДЫ | |
| Wang et al. | Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance | |
| Yu et al. | Boron delivery systems for enhanced boron neutron capture therapy: a comprehensive review | |
| CN100417421C (zh) | 有机金属碳硼烷靶向制剂的制备方法及制成的靶向制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20241122 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241122 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241219 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250424 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250430 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260318 |